Skip to content
Resources > Reports

Investment Banking Trends and Outlook for 2023

There’s no denying the harsh reality investment bankers are facing: struggling to get deals across the finish line while juggling to keep clients satisfied. With a volatile market afflicted by macroeconomic uncertainty, deals are harder to source, regulators are tightening up, the debt market remains closed, and the amount of reliable and unreliable data is nearly impossible to sort, let alone analyze manually.

Ultimately, these pressures have forced investment banks to keep up with the rapid technological advances that have accelerated the industry forward. Those who rely on outdated processes and resist change will soon be outpaced by progressive institutions, effectively losing out on new clients and talent.

But what does this new wave of technological adoption and doing business look like?

Download our report to learn:

  • The top trends defining the industry, Generative AI to Open Banking
  • What technologies leading nations are adopting to fight economic uncertainty
  • An outlook on the opportunities and challenges that will play out in the IB space

Explore more

Enterprise Software: Assessing AI Adoption Trends

Generative AI is moving from isolated pilots to full-scale deployments, with adoption accelerating in areas like software development and IT service management.
Title slide: Enterprise Software: Assessing AI Adoption Trends, by Michelle Brophy and Sean Carmichael, featuring a computer illustration and AI logo.

From Promise to Performance: How AI Will Evolve in 2026

2025 was the year generative AI grew up, shifting from isolated experiments to integrated systems. What also emerged was a clearer picture of how AI will continue to mature in 2026.
Title slide: From Promise to Performance: How AI Will Evolve in 2026 by Sarah Hoffman, Director of AI Thought Leadership, with abstract tech graphics.

Most-Favored-Nation Policy: Implications for European Drug Launches

The U.S. shift toward most-favored-nation (MFN) drug pricing is forcing pharmaceutical firms to rethink their pricing models and launch strategies in Europe.
U.S. Most-Favored-Nation Drug Pricing Policy: What Does It Mean for Europe? by Sara Mallatt and Sean Carmichael, with a stylized map of Europe.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.